Incidental thyroid carcinoma in thyrotoxic patients treated by surgery

被引:22
作者
Cakir, Mehtap
Arici, Cumhur
Alakus, Huseyin
Altunbas, Hasan
Balci, Mustafa Kemal
Karayalcin, Umit
机构
[1] Akdeniz Univ, Div Endocrinol & Metab, Sch Med, Antalya, Turkey
[2] Akdeniz Univ, Dept Gen Surg, Sch Med, Antalya, Turkey
关键词
thyrotoxicosis; Graves' disease; toxic nodular goiter; thyroid carcinoma; thyroidectomy;
D O I
10.1159/000096357
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background and Aims: Thyroid malignancy detected incidentally in patients who are operated for thyrotoxicosis has been reported at different rates. The aim of this study was to investigate the rate of incidental thyroid carcinoma in thyrotoxic patients managed with surgery in our institution. Methods: Of the 375 thyrotoxic patients who had thyroid surgery between the years of 1997-2004, 70.7% were females and 29.3% were males. Among thyrotoxic patients 65.3% (n = 245) had toxic multinodular goiter (TMG), 16.8% (n = 63) had toxic adenoma (TA) and 17.9% (n = 67) had Graves' disease. Results: Twenty-six (6.9%) of all thyrotoxic patients had thyroid carcinoma. Eighteen (7.3%) of TMG, 4 (6.3%) of TA and 4 (6%) of Graves' disease patients had thyroid carcinoma. Histologic examination revealed 18 papillary (9 microscopic), 5 follicular, 2 hurthle cell and 1 anaplastic carcinoma. Conclusion: In our study, incidental thyroid carcinoma was found in 6.9% of subjects with thyrotoxicosis. Papillary thyroid microcarcinomas constituted 34.6% (26/9) of these newly diagnosed thyroid carcinomas. The incidence of thyroid carcinoma was not higher in subjects with Graves' disease compared to TMG and TA. The rate of incidental thyroid carcinoma in subjects with thyrotoxicosis treated with surgery was similar to previous studies reported from different countries. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:96 / 99
页数:4
相关论文
共 25 条
[1]
Thyrotropin receptor antibodies: new insights into their actions and clinical relevance [J].
Ando, T ;
Latif, R ;
Davies, TF .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 19 (01) :33-52
[2]
Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country [J].
BacherStier, C ;
Riccabona, G ;
Totsch, M ;
Kemmler, G ;
Oberaigner, W ;
Moncayo, R .
THYROID, 1997, 7 (05) :733-741
[3]
DECREASE OF INCIDENCE OF TOXIC NODULAR GOITER IN A REGION OF SWITZERLAND AFTER FULL CORRECTION OF MILD IODINE DEFICIENCY [J].
BALTISBERGER, BL ;
MINDER, CE ;
BURGI, H .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (05) :546-549
[4]
Graves' disease, thyroid nodules and thyroid cancer [J].
Belfiore, A ;
Russo, D ;
Vigneri, R ;
Filetti, S .
CLINICAL ENDOCRINOLOGY, 2001, 55 (06) :711-718
[5]
CANCER RISK IN PATIENTS WITH COLD THYROID-NODULES - RELEVANCE OF IODINE INTAKE, SEX, AGE, AND MULTINODULARITY [J].
BELFIORE, A ;
LAROSA, GL ;
LAPORTA, GA ;
GIUFFRIDA, D ;
MILAZZO, G ;
LUPO, L ;
REGALBUTO, C ;
VIGNERI, R .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (04) :363-369
[6]
The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency [J].
Burgess, JR ;
Dwyer, T ;
McArdle, K ;
Tucker, P ;
Shugg, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (04) :1513-1517
[7]
Iodine deficiency in Calabria: Characterization of endemic goiter and analysis of different indicators of iodine status region-wide [J].
Costante, G ;
Grasso, L ;
Schifino, E ;
Marasco, MF ;
Crocetti, U ;
Capula, C ;
Chiarella, R ;
Ludovico, O ;
Nocera, M ;
Parlato, G ;
Filetti, S .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (03) :201-207
[8]
Iodine supplementation - Benefits outweigh risks [J].
Delange, F ;
Lecomte, P .
DRUG SAFETY, 2000, 22 (02) :89-95
[9]
Iodine and Cancer [J].
Feldt-Rasmussen, U .
THYROID, 2001, 11 (05) :483-486
[10]
Iodine intake and thyroid carcinoma - A potential risk factor [J].
Franceschi, S .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 :S38-S44